Reduced radiation exposure

Author(s): Ian S Armstrong

Hospital: Central Manchester University Hospital

Reference: RAD Magazine, 42, 499, 11


The growing demand for PETCT in oncology posed a challenge for Central Manchester University Hospitals NHS Foundation Trust, with a projected 14 per cent annual increase in scanning numbers. Its use of F18 Fludeoxyglucose (18F-FDG) in oncology produced reliable results, but there was a clear need to increase efficiency to accommodate this increasing demand. Additionally, departmental physicists were looking for ways to reduce dose exposure while maintaining the same high quality results. Both staff and patients, some of them relatively young, were being exposed to high levels of ionising radiation during PETCT scans.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more